TRANSMEDICS GROUP, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 127.2 USD | -0.05% |
|
+8.18% | +61.18% |
| May. 08 | Transmedics Group Insider Sold Shares Worth $3,902,100, According to a Recent SEC Filing | MT |
| May. 08 | Transmedics Group Insider Sold Shares Worth $759,479, According to a Recent SEC Filing | MT |
Presentation Operator MessageOperator (Operator)Good afternoon, and welcome to TransMedics Sec...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside of the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ retrieval, OCS organ management and logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation, ground transportation and other coordination activity. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
Calendar
2024-05-23
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
127.2
USD
Average target price
120.5
USD
Spread / Average Target
-5.28%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +61.18% | 4.19B | |
| +8.07% | 219B | |
| +7.87% | 185B | |
| +12.75% | 135B | |
| -1.37% | 62.21B | |
| +4.88% | 51.01B | |
| +11.59% | 51.28B | |
| +2.71% | 41.85B | |
| +4.90% | 37.02B | |
| +23.75% | 31.27B |
- Stock Market
- Equities
- TMDX Stock
- News TransMedics Group, Inc.
- Transcript : TransMedics Group, Inc., Q2 2023 Earnings Call, Aug 03, 2023